ARCHIVES

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

This article is from The Cancer Letter archive.

Vol. 05 No. 21 | May 25, 1979

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Takes Summer Publication Break.

August 2, 2002

NCI, HCFA Negotiate Demonstration Project as Congress, Advocates Exert Pressure

September 27, 1996

CGAP Speeding Gene Discovery

April 30, 1999

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980